Resverlogix initiates phase II diabetes trials

Clinical Research |  News | By BioSpectrum Bureau  | 0 Comment | 17 Oct, 2012

Singapore: Resverlogix has initiated an exploratory phase II clinical trial in patients with pre-diabetes mellitus to examine the effects of RVX-208 and ApoA-I production on glucose metabo...Read more

Marken gets 12-year license in China

Clinical Research |  News | By BioSpectrum Bureau  | 0 Comment | 05 Oct, 2012

Singapore: Global clinical supply chain solutions provider Marken has been granted a 12-year license to ship biological samples and drug product within China. Marken plans to continue its e...Read more

Which domain of clinical research do APAC CROs focus on?

Clinical Research |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2013

The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more

Good Clinical Practice-certified investigators ensure quality in Malaysia

Clinical Research |  Opinion | By BioSpectrum Bureau  | 0 Comment | 17 Sep, 2013

The clinical trials landscape in Malaysia is very easy to navigate. The Malaysian government has been actively promoting clinical trials and other facets of biomedical development for man...Read more

Marc Wolff is CFO of ReSearch Pharma Services

Clinical Research |  News | By BioSpectrum Bureau  | 0 Comment | 25 Jul, 2013

‎Singapore: ReSearch Pharmaceutical Services, a clinical research firm, has appointed Mr Marc Wolff as its chief financial officer.In this role, Mr Wolff will direct all financial, ta...Read more

Patrys' multiple myeloma clinical trial progresses

Clinical Research |  News | By BioSpectrum Bureau  | 0 Comment | 12 Aug, 2013

Singapore: Patrys, a clinical stage biotechnology company, has received approval to progress its Phase I/IIa PAT-SM6 multiple myeloma trial to its fourth and final group of patients, based ...Read more

Agilent LC/MS for 'dried blood-spot analysis'

Clinical Research |  News | By BioSpectrum Bureau  | 0 Comment | 22 May, 2012

Singapore: Agilent Technologies has introduced the Agilent Automated Card Extraction LC/MS system, a fully integrated instrument for the analysis of dried blood spots and other dried media....Read more

Mesoblast NeoFuse shows +ve results

Clinical Research |  News | By BioSpectrum Bureau  | 0 Comment | 14 Jan, 2013

Singapore: Regenerative medicine company Mesoblast's phase II clinical trial for lumbar spinal fusion successfully met its safety and efficacy endpoints. The results suggest that Mesoblas...Read more

Japanese firm to begin clinical research in Bahrain

Clinical Research |  News | By BioSpectrum Bureau  | 0 Comment | 01 Feb, 2013

Singapore: SBI Pharmaceuticals, headquartered in Japan, has concluded a basic agreement to begin clinical research on diabetes in Bahrain with the Arabian Gulf University. The company resea...Read more

Quintiles gets CAP's first-ever Asia accreditation

Clinical Research |  News | By BioSpectrum Bureau  | 0 Comment | 17 Jan, 2013

Mumbai: Quintiles announced that its central laboratory in Mumbai, India, has received accreditation from the College of American Pathologists 15189SM Accreditation Program, becoming the f...Read more

Corruption hampers China's growth

Clinical Research |  Analysis | By BioSpectrum Bureau  | 0 Comment | 05 Sep, 2013

The growth story of the clinical research industry in China speaks of perfection, good timing and untapped potential. All the basic characteristics that are native to China further add to i...Read more

Iconik Monitoring to aid in real time data analysis

Clinical Research |  News | By BioSpectrum Bureau  | 0 Comment | 22 Aug, 2013

Singapore: Icon, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, launched Iconik Monitoring, the first in a series o...Read more

Sanofi declares results of Lantus clinical trial

Clinical Research |  News | By BioSpectrum Bureau  | 0 Comment | 12 Jun, 2012

Bangalore: The results of the landmark ORIGIN (Outcome Reduction with Initial Glargine Intervention) trial showed that Lantus, Sanofi's brand of insulin glargine [rDNA] injection, had no st...Read more

BSA-CMR Survey: Oncology is the top therapeutic focus area for CROs in APAC

Clinical Research |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2013

The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more

Charles River manages 2.9% growth in Q2, 2013

Clinical Research |  Company results | By BioSpectrum Bureau  | 0 Comment | 01 Aug, 2013

Singapore: Drug development company Charles River Laboratories has marked net sales of $292.9 million in the second quarter of 2013, maintaining growth of 2.9 percent from $284.7 million in...Read more

Vietnam, Quintiles enter deal to advance clinical trials

Clinical Research |  News | By BioSpectrum Bureau  | 0 Comment | 21 Nov, 2013

Singapore: Vietnam Ministry of Health's Administration of Science, Technology and Training (ASTT) has signed an agreement with Quintiles to enhance clinical research in this growing nation ...Read more

INC Research expands in Korea to meet local demand

Clinical Research |  News | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2012

Singapore: INC Research, a therapeutically focused clinical research organization (CRO) with a trusted process for delivering reliable results, opened a facility in South Korea to manage t...Read more

NIH cancels 40 ongoing clinical trials in India

Clinical Research |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 12 Jul, 2013

Singapore: In what is proving to be a major setback for the Indian clinical research industry, reports reveal that the world's largest research funder, the National Institutes of Health (NI...Read more